Research Grant Awards
The Fanconi Cancer Foundation Research Grant Awards fund innovative research into the biology, treatment, and understanding of Fanconi anemia, supporting both preclinical and clinical science.
Funder: Fanconi Cancer Foundation
Due Dates (Anticipated): October 2026 (Letter of Intent) | February 2027 (Full proposal) | March 2027 (Letter of Intent) | March 2027 (Letter of Intent) | June 2027 (Full proposal)
Funding Amounts: $25,000–$250,000 per award, typically for 1–2 years, milestone-based; no indirect costs allowed.
Summary: Supports innovative interdisciplinary and translational research advancing therapies, understanding, and resources for Fanconi anemia.
Key Information: Letter of Intent required; open to US and international researchers with PhD, MD, or equivalent.
Description
The Fanconi Cancer Foundation Research Grant Awards fund interdisciplinary and translational research projects that accelerate the discovery and development of therapies or strategies to treat, control, or cure Fanconi anemia (FA). The program emphasizes projects addressing critical research priorities such as FA-associated cancer pathogenesis, novel gene therapies, bone marrow failure, systemic and aging manifestations, quality of life improvements, data analytics for new insights, and the creation of shared research resources. The Foundation seeks innovative proposals with the potential for significant impact on disease understanding and patient care, welcoming both preclinical and clinical research.
